Skip to main content

Solstein Capital, LLC

SEC CIK
0001730769
Latest filing
Aug 12, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Solstein Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
794
Value
$38.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Solstein Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026794$38.1K<0.1%00.0%UnchangedHolders
Q1 2026794$29.2K<0.1%00.0%UnchangedHolders
Q4 2025794$40.4K<0.1%00.0%UnchangedHolders
Q3 2025794$44.1K<0.1%−14,483−94.8%ReducedHolders
Q2 202515,277$1.05M0.5%00.0%UnchangedHolders
Q1 202515,277$1.06M0.6%−5,560−26.7%ReducedHolders
Q4 202420,837$1.79M1.0%−5,000−19.4%ReducedHolders
Q3 202425,837$3.08M1.6%−5,000−16.2%ReducedHolders
Q2 202430,837$4.40M2.9%00.0%UnchangedHolders
Q1 202430,837$3.96M2.7%−921−2.9%ReducedHolders
Q4 202331,758$3.29M2.4%+28+0.1%AddedHolders
Q3 202331,730$2.89M2.5%00.0%UnchangedConverted for a 2-for-1 splitHolders
Q2 202315,865$2.57M2.1%+190+1.2%AddedHolders
Q1 202315,675$2.49M2.2%−1,145−6.8%ReducedHolders
Q4 202216,820$2.28M1.9%−1,764−9.5%ReducedHolders
Q3 202218,584$1.85M1.6%+144+0.8%AddedHolders
Q2 202218,440$2.06M1.6%+193+1.1%AddedHolders
Q1 202218,247$2.03M1.3%−544−2.9%ReducedHolders
Q4 202118,791$2.10M1.3%−391−2.0%ReducedHolders
Q3 202119,182$1.84M1.1%+12,760+198.7%AddedHolders
Q2 20216,422$538.0K0.7%−45−0.7%ReducedHolders
Q1 20216,467$436.0K0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.